Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (173)	4/9/1998 9:10:00 AM
From: Biomaven	Read Replies (1) of 3044

John, <<MCDE expected to meet all expenses from it's cash flow for next 5 years.>> Just to clarify, I was referring to CBST when I said it looked to me like they'd need to raise money this year. Maybe we should just keep talking about them on this thread, seeing we're all here already. They're related to MLNM because they're all "undervalued biotechs" <G> or maybe :(. ALthough MCDE and CBST are the pure plays, a number of biotechs I follow seem to be jumping on this problem (e.g., SEPR and NXTR). It's a nice, simple story, so I'm surprised that MCDE and CBST haven't attracted more attention. I think at this point CBST is going to be driven by the drug they licensed from Lilly (Daptomycin), rather than by its own pipeline. This was an interesting strategy, by the way - makes the company look "real" much sooner, and maybe people will foreget they didn't develop the drug themselves (like Viracept and AGPH). I wonder why Lilly licensed the drug? Milestones are to be paid in stock, by the way. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next